HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DSM Makes Waves In Omega-3 Fish Oil With Ocean Nutrition Pick-Up

This article was originally published in The Tan Sheet

Executive Summary

The Dutch ingredients company hopes to expand Ocean Nutrition Canada into a global omega-3 fish oil supplier for foods and supplements, as well as a source for pharma ingredients. With expiring IP on the Martek algal DHA process, DSM could be seeking a hedge.

You may also be interested in...



Alcresta Investment Reflects Omega Market Growth

Alcresta is developing omega-3 and -6 fatty acid supplements that are more easily digested and absorbable. Founders Alexey Margolin and Robert Gallotto look to repeat the success they had in 2010 when they sold an earlier nutritionals start-up for $180 million.

In Brief

FDA extends phytosterol enforcement discretion; Perrigo debuts Claritin-D 12 Hour equivalent; Reckitt sells Indian personal care brands acquired from Paras; Ocean Nutrition Canada gets vertical; more news In Brief.

Amerifit Shoulders More Responsibility As DSM's "Conduit To The Consumer"

Amerifit Brands launches its first products since Martek Biosciences acquired it, and executives expect continued expansion as DSM integrates the supplement marketer.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS125133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel